Galectin-3 and Its Role in Gastric Cancer Cell Movement
Author Information
Author(s): Kim Seok-Jun, Shin Ji-Young, Lee Kang-Duck, Bae Young-Ki, Choi Il-Ju, Park Seok Hee, Chun Kyung-Hee
Primary Institution: National Cancer Center Research Institute and Hospital
Hypothesis
Galectin-3, PAR-1, and MMP-1 may enhance the migration and invasion of gastric cancer cells.
Conclusion
Galectin-3 enhances gastric cancer cell motility by up-regulating PAR-1 and MMP-1, which may serve as potential therapeutic targets.
Supporting Evidence
- Galectin-3 silencing decreases PAR-1 expression.
- Over-expression of galectin-3 increases cell migration and invasion.
- Silencing of galectin-3, PAR-1, or MMP-1 significantly reduces cell migration.
- Galectin-3 interacts with AP-1 transcriptional factor to drive PAR-1 transcription.
- MMP-1 silencing blocks cell invasion caused by galectin-3 over-expression.
Takeaway
Galectin-3 helps cancer cells move around more, which can make cancer spread. Scientists think it could be a good target for new treatments.
Methodology
The study involved silencing galectin-3, PAR-1, and MMP-1 in gastric cancer cells and using a zebrafish model to analyze cell migration and invasion.
Limitations
The study primarily focuses on in vitro and zebrafish models, which may not fully replicate human gastric cancer behavior.
Participant Demographics
20 gastric cancer patients were included for tissue analysis.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website